Literature DB >> 25716449

Differential immunodetection of toxin B from highly virulent Clostridium difficile BI/NAP-1/027.

Nira R Pollock1, Linan Song2, Mingwei Zhao2, David C Duffy2, Xinhua Chen3, Susan P Sambol4, Dale N Gerding4, Ciarán P Kelly3.   

Abstract

We developed a simple immunoassay capable of differentially detecting toxin B from highly virulent strains of Clostridium difficile (BI/NAP-1/027) in stool. This assay can simultaneously confirm the presence of in vivo toxin production and provide strain-related information relevant to infection control epidemiology and disease prognosis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25716449      PMCID： PMC4400753          DOI： 10.1128/JCM.03419-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

3.  Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

Authors:  Abraham Goorhuis; Dennis Bakker; Jeroen Corver; Sylvia B Debast; Celine Harmanus; Daan W Notermans; Aldert A Bergwerff; Frido W Dekker; Ed J Kuijper
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

4.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

5.  Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Authors:  Fred C Tenover; Susan Novak-Weekley; Christopher W Woods; Lance R Peterson; Thomas Davis; Paul Schreckenberger; Ferric C Fang; Andre Dascal; Dale N Gerding; Jim H Nomura; Richard V Goering; Thomas Akerlund; Alice S Weissfeld; Ellen Jo Baron; Edith Wong; Elizabeth M Marlowe; Joseph Whitmore; David H Persing
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

6.  Isolation and detection of single molecules on paramagnetic beads using sequential fluid flows in microfabricated polymer array assemblies.

Authors:  Cheuk W Kan; Andrew J Rivnak; Todd G Campbell; Tomasz Piech; David M Rissin; Matthias Mösl; Andrej Peterça; Hans-Peter Niederberger; Kaitlin A Minnehan; Purvish P Patel; Evan P Ferrell; Raymond E Meyer; Lei Chang; David H Wilson; David R Fournier; David C Duffy
Journal:  Lab Chip       Date:  2011-12-16       Impact factor: 6.799

7.  Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.

Authors:  Odile Letourneur; Sophie Ottone; Vincent Delauzun; Marie-Claire Bastide; Agnès Foussadier
Journal:  Protein Expr Purif       Date:  2003-10       Impact factor: 1.650

Review 8.  Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.

Authors:  Maja Rupnik
Journal:  FEMS Microbiol Rev       Date:  2008-04-03       Impact factor: 16.408

9.  Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain.

Authors:  Sze K Lim; Rhonda L Stuart; Kate E Mackin; Glen P Carter; Despina Kotsanas; Michelle J Francis; Marion Easton; Karolina Dimovski; Briony Elliott; Thomas V Riley; Geoff Hogg; Eldho Paul; Tony M Korman; Torsten Seemann; Timothy P Stinear; Dena Lyras; Grant A Jenkin
Journal:  Clin Infect Dis       Date:  2014-04-04       Impact factor: 9.079

10.  Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.

Authors:  David M Rissin; Cheuk W Kan; Todd G Campbell; Stuart C Howes; David R Fournier; Linan Song; Tomasz Piech; Purvish P Patel; Lei Chang; Andrew J Rivnak; Evan P Ferrell; Jeffrey D Randall; Gail K Provuncher; David R Walt; David C Duffy
Journal:  Nat Biotechnol       Date:  2010-05-23       Impact factor: 54.908
View more
  9 in total

Review 1.  Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.

Authors:  Nira R Pollock
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

Review 2.  Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

3.  Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.

Authors:  Nira R Pollock; Alice Banz; Xinhua Chen; David Williams; Hua Xu; Christine A Cuddemi; Alice X Cui; Matthew Perrotta; Eaman Alhassan; Brigitte Riou; Aude Lantz; Mark A Miller; Ciaran P Kelly
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

4.  Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.

Authors:  Ciaran P Kelly; Xinhua Chen; David Williams; Hua Xu; Christine A Cuddemi; Kaitlyn Daugherty; Caitlin Barrett; Mark Miller; Agnès Foussadier; Aude Lantz; Alice Banz; Nira R Pollock
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

5.  Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.

Authors:  Carolyn D Alonso; Ciarán P Kelly; Kevin W Garey; Anne J Gonzales-Luna; David Williams; Kaitlyn Daugherty; Christine Cuddemi; Javier Villafuerte-Gálvez; Nicole C White; Xinhua Chen; Hua Xu; Rebecca Sprague; Caitlin Barrett; Mark Miller; Agnès Foussadier; Aude Lantz; Alice Banz; Nira R Pollock
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

6.  Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype.

Authors:  Qianyun Lin; Nira R Pollock; Alice Banz; Aude Lantz; Hua Xu; Limei Gu; Dale N Gerding; Kevin W Garey; Anne J Gonzales-Luna; Mingwei Zhao; Linan Song; David C Duffy; Ciaran P Kelly; Xinhua Chen
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

7.  A Rapid, Accurate, Single Molecule Counting Method Detects Clostridium difficile Toxin B in Stool Samples.

Authors:  Sadanand Gite; Destiny Archambault; Michael P Cappillino; David Cunha; Victoria Dorich; Tatyana Shatova; Andrew Tempesta; Bruce Walsh; Jessica A Walsh; Adam Williams; James E Kirby; Jayson Bowers; Don Straus
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 8.  A critical review: Recent advances in "digital" biomolecule detection with single copy sensitivity.

Authors:  Haomin Liu; Yu Lei
Journal:  Biosens Bioelectron       Date:  2021-01-04       Impact factor: 10.618

9.  Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.

Authors:  Alice Banz; Aude Lantz; Brigitte Riou; Agnès Foussadier; Mark Miller; Kerrie Davies; Mark Wilcox
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.